Skip to main content
construction release_alert
Scholars@Duke will be down for maintenance for approximately one hour starting Tuesday, 11/11 @1pm ET
cancel

Brandi Tranae’ Johnson-Weaver

Assistant Professor in Pathology
Pathology
Box 3712, 346 Davison Building, Durham, NC 27710
40 Medicine Circle, 346 Davison Building, Durham, NC 27710

Overview


Vaccines, as invaluable public health tools, modulate host immune responses to induce prophylactic protection against infectious diseases and also serve as potential therapeutics to treat established diseases, such as food allergies. My research aims to identify environmental exposures that modulate host responses to harmful insults, including pathogens, allergens, and drug abuse while utilizing vaccination to regulate immunity to protect the host from harm. One goal of my research is to identify innovative vaccine strategies that incorporate novel adjuvants and formulations to induce protective immunity against several diseases when applied to a mucosal surface. Our laboratory also focuses on identifying host immune responses that correlate with protection against several diseases, including peanut allergies and opioid use disorder, and developing novel adjuvanted vaccine formulations that enhance the magnitude, durability, and efficacy of protective immunity. We also investigate the innovative contribution of environmental factors on host immune responses, including susceptibility to allergen sensitization and response to immunization. Understanding how or why a particular immune response is induced in a host may lead to developing targeted treatment options that are safer and more effective than current therapies.

Current Appointments & Affiliations


Assistant Professor in Pathology · 2025 - Present Pathology, Clinical Science Departments

Recent Publications


Nasal immunization with compound 48/80-adjuvanted acellular pertussis vaccines is an effective strategy to induce pertussis-specific systemic and mucosal immunity.

Journal Article Clin Exp Vaccine Res · July 2025 PURPOSE: Mast cell activating adjuvants induce vaccine-specific systemic and mucosal immunity when administered intranasally. Bordetella pertussis infects the respiratory tract and caused 0.45% childhood mortality in the United States before implementing p ... Full text Link to item Cite

Two doses of Qβ virus like particle vaccines elicit protective antibodies against heroin and fentanyl.

Journal Article NPJ Vaccines · March 28, 2025 Opioid overdoses and opioid use disorder (OUD) are major public health concerns. Current treatment approaches for OUD have failed to slow the growth of the opioid crisis. Opioid vaccines have shown pre-clinical success in targeting multiple different opioi ... Full text Link to item Cite

A two-dose regimen of Qβ virus-like particle-based vaccines elicit protective antibodies against heroin and fentanyl.

Journal Article bioRxiv · August 29, 2024 Opioid overdoses and the growing rate of opioid use disorder (OUD) are major public health concerns, particularly in the United States. Current treatment approaches for OUD have failed to slow the growth of the opioid crisis. Opioid vaccines have shown pre ... Full text Link to item Cite
View All Publications

Recent Grants


Bacteriophage virus-like particle vaccines for fentanyl and heroin overdose

ResearchPrincipal Investigator · Awarded by University of New Mexico · 2021 - 2028

Adjuvant Comparison for Peanut Allergy Immunotherapy

ResearchProject Manager · Awarded by National Institutes of Health · 2022 - 2026

Adjuvant Comparison for Peanut Allergy Immunotherapy

ResearchProject Manager · Awarded by National Institutes of Health · 2022 - 2026

View All Grants

Education, Training & Certifications


Duke University, School of Medicine · 2015 Ph.D.